The Limits of Law in Regulating Health Care Decisions
dc.contributor.author | Burt, Robert | |
dc.date | 2021-11-25T13:34:54.000 | |
dc.date.accessioned | 2021-11-26T11:48:55Z | |
dc.date.available | 2021-11-26T11:48:55Z | |
dc.date.issued | 1977-01-01T00:00:00-08:00 | |
dc.identifier | fss_papers/795 | |
dc.identifier.contextkey | 1650283 | |
dc.identifier.uri | http://hdl.handle.net/20.500.13051/5197 | |
dc.description.abstract | The case for legal regulation of biomedical technology used to be easy to argue. A decade ago, it was clear that this technology had a dramatic impact on issues of far-reaching public significance, that many of these issues were not being systematically addressed by anyone, and that others were being considered only by physicians and biological scientists from a very narrow perspective. The argument for systematic law-making in the resolution of these issues was easy and, during the past few years, that argument seems in large part to have prevailed. Congres- sional establishment of the National Commission for Pro- tection of Human Subjects of Behavioral and Biomedical Research, with its wide-ranging statutory jurisdiction, is one indication of this trend. The California "Natural Death Act" is another. A third indication is the current willingness of judges to enter into previously sacrosanct medical territory, to proclaim principles of "informed con- sent" for doctor/patient relations or "rights to treatment" for institutionalized mentally ill or retarded persons. | |
dc.title | The Limits of Law in Regulating Health Care Decisions | |
dc.source.journaltitle | Faculty Scholarship Series | |
refterms.dateFOA | 2021-11-26T11:48:55Z | |
dc.identifier.legacycoverpage | https://digitalcommons.law.yale.edu/fss_papers/795 | |
dc.identifier.legacyfulltext | https://digitalcommons.law.yale.edu/cgi/viewcontent.cgi?article=1805&context=fss_papers&unstamped=1 |